vaccine: Latest News

All news where vaccine is mentioned

COVID-19 vaccination: consent forms and letters for care home residents - gov.uk
gov.uk
49%
231
COVID-19 vaccination: consent forms and letters for care home residents
PDF, 52.1 KB, 1 pageThis file may not be suitable for users of assistive technology.ODT, 27.1 KB This file is in an format This file may not be suitable for users of assistive technology.MS Word Document, 134 KBThis file may not be suitable for users of assistive technology.ODT, 22.1 KB This file is in an format This file may not be suitable for users of assistive technology.MS Word Document, 35.3 KBThis file may not be suitable for users of assistive technology.Ref: PHE gateway number 2020367PDF, 52.3 KB, 1 pageThis file may not be suitable for users of assistive technology.ODT, 27.7 KB This file is in an format This file may not be suitable for users of assistive technology.MS Word Document, 134 KBThis file may not be suitable for users of assistive technology.ODT, 22.6 KB This file is in an format This file may not be suitable for users of assistive technology.MS Word Document, 37.2 KBThis file may not be suitable for users of assistive technology.Ref: PHE gateway number 2020368PDF, 52.6 KB, 1 pageThis file may not be suitable for users of assistive technology.ODT, 28.3 KB This file is in an format This file may not be suitable for users of assistive technology.MS Word Document, 136 KBThis file may not be suitable for users of assistive technology.ODT, 23 KB This file is in an format This file may not be suitable for users of assistive technology.MS Word Document, 36.3 KBThis file may not be suitable for users of assistive technology.When considering a decision made in someone’s best interests, the past views of the person should be taken into account.
COVID-19: the green book, chapter 14a - gov.uk
gov.uk
89%
162
COVID-19: the green book, chapter 14a
PDF, 746 KB, 57 pagesThis file may not be suitable for users of assistive technology.This chapter includes information on:Updated mention of a table.Updated to include JCVI advice on vaccination for children aged 6 months to 4 years in a clinical risk group.Updated storage information for VidPrevtyn.Updated to include shortened background, separation between the historical pandemic response and the ongoing programme, spring booster campaign, explanation of the end of universal primary and booster offers, and describing the move to only offer vaccine during seasonal campaigns.Updated to include approval of Pfizer bivalent vaccine and further clarification around vaccination of under 12 year olds.Updated to include information on the autumn programme and variant vaccines, and further clarification of information on revaccination and capillary leak syndrome.Updated to include: approval of Novavax, clarification around deferral after COVID-19 infection, one-off programme for 5 to 11 year olds who are not in clinical risk groups, advice on use of the paediatric formulation in those aged 12 years, spring booster recommendations (including flexibility around timing) and expectations for an autumn booster, clarification of the management of individuals with a history of allergic reactions, updated advice on management of people who have ITP following vaccination.Updated background to include latest data on vaccine effectiveness and booster safety; clarified and corrected chronology of booster advice.
DMCA